Lack of association between catalase gene polymorphism (T/C exon 9) and susceptibility to vitiligo in a Turkish population

Genetics and Molecular Research

Volumn 10, Issue 4, 2011, Pages 4126-4132

  Bulut, H ^a   Pehlivan, M ^b   Alper, S ^a   Tomatir, A G ^c   Onay, H ^a   Yuksel S E ^a   Ozkinay F ^a   Pehlivan, S ^a,b  

^a EGE UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

^c PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Melanocytes; Oxidative stress catalase gene (CAT); PCR RFLP; Vitiligo

Indexed keywords

CATALASE; HYDROGEN PEROXIDE;

ARTICLE; CAT GENE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; TURK (PEOPLE); VITILIGO; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

CATALASE; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYDROGEN PEROXIDE; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TURKEY; VITILIGO;

EID: 84866777176     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2011.October.31.12     Document Type: Article

References (35)

1. Alkhateeb A, Stetler GL, Old W, Talbert J, et al. (2002). Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum. Mol. Genet. 11: 661-667.
2. Alkhateeb A, Fain PR, Thody A, Bennett DC, et al. (2003). Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 16: 208-214.
3. Arcos-Burgos M, Parodi E, Salgar M, Bedoya E, et al. (2002). Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum. Genet. 110: 334-342.
4. Barona MI, Arrunategui A, Falabella R and Alzate A (1995). An epidemiologic case-control study in a population with vitiligo. J. Am. Acad. Dermatol. 33: 621-625.
5. Bell GI, Najarian RC, Mullenbach GT and Hallewell RA (1986). cDNA sequence coding for human kidney catalase. Nucleic Acids Res. 14: 5561-5562.
6. Casp CB, She JX and McCormack WT (2002). Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res. 15: 62-66.
7. Casp CB, She JX and McCormack WT (2003). Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo. Genes Immun. 4: 492-499.
8. Chen JJ, Huang W, Gui JP, Yang S, et al. (2005). A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families. Am. J. Hum. Genet. 76: 1057-1065.
9. Das SK, Majumder PP, Chakraborty R, Majumdar TK, et al. (1985a). Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet. Epidemiol. 2: 71-78.
10. Das SK, Majumder PP, Majumdar TK and Haldar B (1985b). Studies on vitiligo. II. Familial aggregation and genetics. Genet. Epidemiol. 2: 255-262.
11. Em S, Laddha NC, Chatterjee S, Gani AR, et al. (2007). Association of catalase T/C exon 9 and glutathione peroxidase codon 200 polymorphisms in relation to their activities and oxidative stress with vitiligo susceptibility in Gujarat population. Pigment Cell Res. 20: 405-407.
12. Fain PR, Gowan K, LaBerge GS, Alkhateeb A, et al. (2003). A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am. J. Hum. Genet. 72: 1560-1564.
13. Forsberg L, Lyrenas L, de FU and Morgenstern R (2001). A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic. Biol. Med. 30: 500-505.
14. Gavalas NG, Akhtar S, Gawkrodger DJ, Watson PF, et al. (2006). Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo. Biochem. Biophys. Res. Commun. 345: 1586-1591.
15. Góth L, Rass P and Madarasi I (2001). A novel catalase mutation detected by polymerase chain reaction-single strand conformation polymorphism, nucleotide sequencing, and western blot analyses is responsible for the type C of Hungarian acatalasemia. Electrophoresis 22: 49-51.
16. Hafez M, Sharaf L and Abd el-Nabi SM (1983). The genetics of vitiligo. Acta Derm. Venereol. 63: 249-251.
17. Hann SK and Nordlund JJ (2000). Vitiligo. Blackwell Science, Oxford.
18. Howitz J, Brodthagen H, Schwartz M and Thomsen K (1977). Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch. Dermatol. 113: 47-52.
19. Jin SY, Park HH, Li GZ, Lee HJ, et al. (2004). Association of angiotensin converting enzyme gene I/D polymorphism of vitiligo in Korean population. Pigment Cell Res. 17: 84-86.
20. Le Poole IC, Sarangarajan R, Zhao Y, Stennett LS, et al. (2001). 'VIT1', a novel gene associated with vitiligo. Pigment Cell Res. 14: 475-484.
21. Lv YJ, Liao WJ, Luan Q, Wang H, et al. (2011). The polymorphism of catalase T/C codon 389 in exon 9 and vitiligo susceptibility: a meta-analysis. J. Eur. Acad. Dermatol. Venereol. 25: 955-958.
22. Majumder PP, Das SK and Li CC (1988). A genetical model for vitiligo. Am. J. Hum. Genet. 43: 119-125.
23. Majumder PP, Nordlund JJ and Nath SK (1993). Pattern of familial aggregation of vitiligo. Arch. Dermatol. 129: 994-998.
24. Maresca V, Roccella M, Roccella F, Camera E, et al. (1997). Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J. Invest. Dermatol. 109: 310-313.
25. Mehta NR, Shah KC, Theodore C, Vyas VP, et al. (1973). Epidemiological study of vitiligo in Surat area, South Gujarat. Indian J. Med. Res. 61: 145-154.
26. Nath SK, Majumder PP and Nordlund JJ (1994). Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am. J. Hum. Genet. 55: 981-990.
27. Nordlund JJ (1997). The epidemiology and genetics of vitiligo. Clin. Dermatol. 15: 875-878.
28. Park HH, Ha E, Uhm YK, Jin SY, et al. (2006). Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population. Exp. Dermatol. 15: 377-380.
29. Schallreuter KU, Wood JM and Berger J (1991). Low catalase levels in the epidermis of patients with vitiligo. J. Invest. Dermatol. 97: 1081-1085.
30. Schallreuter KU, Moore J, Wood JM, Beazley WD, et al. (1999). In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J. Investig. Dermatol. Symp. Proc. 4: 91-96.
31. Spritz RA, Gowan K, Bennett DC and Fain PR (2004). Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am. J. Hum. Genet. 74: 188-191.
32. Yang S, Wang JY, Gao M, Liu HS, et al. (2005). Association of HLA-DQA1 and DQB1 genes with vitiligo in Chinese Hans. Int. J. Dermatol. 44: 1022-1027.
33. Zhang XJ, Liu JB, Gui JP, Li M, et al. (2004a). Characteristics of genetic epidemiology and genetic models for vitiligo. J. Am. Acad. Dermatol. 51: 383-390.
34. Zhang XJ, Liu HS, Liang YH, Sun LD, et al. (2004b). Association of HLA class I alleles with vitiligo in Chinese Hans. J. Dermatol. Sci. 35: 165-168.
35. Zhang XJ, Chen JJ and Liu JB (2005). The genetic concept of vitiligo. J. Dermatol. Sci. 39: 137-146.